List of Publications -2011

1047.  Yadav R, Rao VG, Bhat J, Gopi PG, Wares DF. Annual risk of tuberculosis infection among the tribal children of Jhabua, Madhya Pradesh. Indian Pediatr. 2011;48:43-45.

1048.  Radhakrishnan M, Kumar V, Selvakumar N. Mycobacteria in environmental clean-up. ENVIS.2011;2-5.

1049.  Suhadev M, Mahadevan U, Dilip M, Suryanarayanan D, Rajasekaran S, Thomas B. Percentages, process, and patterns of HIV disclosure among the spouses of HIV-infected men in south India. J Int Assoc Physicians AIDS Care (Chic).2011;10:26-29.

1050.  Senbagavalli P, Kumar N, Kaur G, Mehra NK, Geetha ST, Ramanathan VD. Major histocompatibility complex class III ( C2, C4, factor B ) and C3 gene variants in patients with pulmonary tuberculosis. Hum Immunol.2011;72:173-178.

1051.  Padmapriyadarsini C, Ramesh K umar S , Terrin N, Narendran G, Menon PA, Ramachandran G, Subramanyan S, Venkatesan P, Wanke C, Swaminathan S. Dyslipidemia among HIV-infected patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor–based antiretroviral therapy in India . Clin Infect Dis.2011;52:540-546.

1052.  Madhan Kumar M, Tamilmani K, Raja A. Cytokine and chemokine responses to selected early secreted antigenic target-6 and culture filtrate protein-10 peptides in tuberculosis. J Interferon Cytokine Res.2011;31:299-307.

1053.  Swaminathan S, Kabra SK. Childhood tuberculosis challenges and way forward. Indian J Pediatr.2011;78:319-320.

1054.  Mimiaga MJ, Thomas B, Mayer KH, Reisner SL, Menon S, Swaminathan S, Periyasamy M, Johnson CV, Safren SA. Alcohol use and HIV sexual risk among MSM in Chennai , India . Int J STD AIDS.2011;22:121–125.

1055.  Sekar B, Arunagiri K, Kumar BN, Narayanan S, Menaka K, Oommen PK. Detection of Mutations in folp1 , rpoB and gyrA genes of M. leprae by PCR-direct sequencing – A rapid tool for screening drug resistance in leprosy. Lepr Rev.2011;82:36-45.

1056.  Ranjani R, Lakshmi R, Ravi KD, Devika K, Rahman F, Wares DF. Fast track method for the identification of multi-drug tuberculosis on direct clinical specimen using combined drug media. Asian Pacific J Trop Dis.2011;1:47-49.

1057.  Bhat J, Selvakumar N, Rao VG, Gopi PG, Yadav R, Wares DF. Yield of culture of Mycobacterium tuberculosis complex in sputum samples transported from tribal areas. Int J Tuberc Lung Dis.2011;15:478-482.

1058.  Selvaraj P. Vitamin D, Vitamin D receptor, and Cathelicidin in the treatment of tuberculosis. Chapter thirteen. Vitam Horm.2011;86:307-325.

1059.  Devi NP, Chandrasekaran K, Bhavani PK, Thiruvalluvan C, Swaminathan S. Persistence of stunting after highly active antiretroviral therapy in HIV-infected children in south India. Indian Pediatr.2011;48:333-334.

1060.  Ramachandran G, Kumar AK, Swaminathan S. Pharmacokinetics of antituberculosis drugs in children. Indian J Pediatr.2011;78:435-442.

1061.  Dey B, Jain R, Khera A, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK. Latency antigen a -crystallin based vaccination imparts a robust protection against TB by modulating the dynamics of pulmonary cytokines. PLoS ONE.2011;6:1-11.

1062.  Ramadurai M, Ponnuraja C. Non-parametric estimation of the survival probability of children affected by TB meningitis. Int Refereed Res J.2011;II:216-227.

1063.  Joseph P, Rao VB, Mohan NS, Fredrick JS, Ramachandran R, Balambal R, Wares F, Ranjani R, Thomas A. Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu , India . Indian J Med.Res.2011;133:529-534.

1064.  Basirudeen S, Raja A, Balambal R, Thangaraj S, Leportier M, Ippolito G, Girardi E, Lagrange PH, Goletti D. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infectious Dis.2011;11:1-9.

1065.  Suhadev M, Thomas BE, Sakthivel R, Murugesan P, Chandrasekaran V, Charles N, Durga R, Auxilia M, Mathew TA, Wares F. Alcohol use disorders (AUD) among tuberculosis patients: A study from Chennai, south India . PLoS ONE.2011;6:1-6.

1066.  Ramadurai M, Ponnuraja C. A diagnostic check on Cox PH model using residuals for TB meningitis data. Int J Curr Res.2011;33:96-100.

1067.  Swaminathan S, Ramachandran G, Hemanth Kumar AK, Vasantha M, Lakshmi S, Bhavani PK, Ganga Devi NP, Shah I, Ramesh K , Rajasekaran S. Fac tors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India. J Antimicrob Chemother. 2 011;66:1354-1359.

1068.  Tuberculosis Research Centre, Indian Council of Medical Research (ICMR), Chennai , India . Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases. Int J Tuberc Lung Dis.2011;15:782–788.

1069.  Radhakrishnan M, Balagurunathan R, Selvakumar N, Doble M, Kumar V. Bioprospecting of marine derived actinomycetes with special reference to antimycobacterial activity. Indian J Geo-Marine Sci.2011;40:407-410.

1070.  Venkatesh KK, Swaminathan S, Andrews JR, Mayer KH. Tuberculosis and HIV co-infection: screening and treatment strategies. Drugs .2011;71:1133-1152.

1071  Subramanyam B, Kumar V. Effect of bacteriophage lysin on lysogens. Asian Pacific J Trop Biomed.2011;1:306-308.

1072.  Sivakumar S, Selvakumar N, Narayanan S. Drug resistance among different genotypes of Mycobacterium tuberculosis isolated from patients from Tiruvallur, south India . Infect Genet Evol.2011;11:980-986.

1073.  Shriram AN, Krishnamoorthy K, Saha BP, Roy A, Kumaraswami V, Shah WA, Jambulingam P, Vijayachari P. Diurnally subperiodic filariasis in India-prospects of elimination: precept to action? Parasitol Res.2011;109:1-8.

1074.  Ramachandran R, Chandrasekaran V, Muniyandi M, Jaggarajamma K, Bagchi A, Sahu S. Prevalence and risk factors of HIV infection among clients attending ICTCs in six districts of Tamilnadu, south India. AIDS Res Treat.2011;1-7.

1075.  Thangappah RBP, Paramasivan CN, Narayanan S. Evaluating PCR, culture & histopathology in the diagnosis of female genital tuberculosis. Indian J Med Res.2011;134:40-46.

1076.  Ray D, Harikrishna S, Immanuel C, Victor L, Subramanyam S, Kumaraswami V. Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia. Indian J Med Res.2011;134:79-82.

1077.  Venkatesan P, Dharuman C, Gunasekaran S. A comparative study of principal component regression and partial least squares regression with application to FTIR diabetes data. Indian J Sci Technol.2011;4:740-746.

1078.  Senbagavalli P, Anuradha R, Ramanathan VD, Kumaraswami V, Nutman TB, Babu S. Heightened measures of immune complex and complement function and immune complex–mediated granulocyte activation in human lymphatic filariasis. Am J Trop Med Hyg.2011; 85:89–96.

1079.  Natarajan PL , Narayanan S. Mitogen-activated protein kinases mediate the production of B-cell lymphoma 2 protein by Mycobacterium tuberculosis in monocytes. Biochemistry ( Moscow );2011;76:938-950.

1080.  Venkatesan P, Sundaram N. Exponentiated exponential models for survival data. Indian J Sci Technol.2011;4:923-930.

1081.  Joseph J, Rajendran V, Hassan S, Kumar V. Mycobacteriophage Genome Database. Bioinformation.2011;6:393-394.

1082.  Dey B, Jain R, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK . A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis. PLoS ONE.2011;6:1-8.

1083.  Unissa AN, Sudha S, Selvakumar N, Hassan S. Binding of activated isoniazid with acetyl-CoA carboxylase from Mycobacterium tuberculosis. Bioinformation. 2011;7:107-111.

1084.  Sundaramurthi JC, Kumar S, Silambuchelvi K, Hanna LE. Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis. Bioinformation.2011:7:130-133.

1085.  Rao VG, Bhat J, Yadav R, Gopi PG, Selvakumar N, Wares DF. No time to be complacent with the performance of tuberculosis control activities in tribal areas of India . Int J Tuberc Lung Dis.2011;15: 1276-1277.

1086.  Ponnuraja C, Venkatesan P. Bayesian meta-analysis for randomized controlled trials in anti-tuberculosis chemotherapy: A comprehensive approach. Int J Sci Technol.2011;1:127-135.

1087.  Swaminathan S, Padmapriyadarsini C, Venkatesan P, Narendran G, Ramesh K umar S , Iliayas S, Menon PA, Selvaraju S, Pooranagangadevi N, Bhavani PK , Ponnuraja C, Dilip M, Ranjani R. Efficacy and safety of once-daily nevirapine or efavirenz based antiretroviral therapy in HIV-associated tuberculosis: A randomized clinical trial. Clin Infect Dis.2011;53:716-724.

1088.  Karthik Kumar K, Prabu Seenivasan S, Kumar V, Mohan Das T. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents. Carbohydr Res.2011;346:2084-2090.

1089.  Selvaraj P, Alagarasu K, Singh B, Afsal K. CCL5 (RANTES) gene polymorphisms in pulmonary tuberculosis patients of south India . Int J Immunogen.2011;38:397–402.

1090.  Thomas A, Joseph P, Nair D, Rao DVB, Rekha VVB, Selvakumar N, Jaggarajamma K, Balambal R. Extensively drug-resistant tuberculosis: experience at the Tuberculosis Research Cemtre, Chennai , India . Int J Tuberc Lung Dis.2011;15:1323-1325.

1091.  Sundaramurthi JC, Ramanandan P, Brindha S, Subashree CR, Prasad A, Kumaraswami V, Hanna LE. DDTRP – Database of drug targets for resistant pathogens. Bioinformation.2011;7:98-101.

1092.  Jain R, Dey B, Khera A, Srivastav P, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK. Over-expression of superoxide dismutase obliterates the protective effect of BCG against tuberculosis by modulating innate and adaptive immune responses. Vaccine.2011;29:8118-8125.

1093.  Unissa AN, Sudha S, Selvakumar N. E lucidating pyrazinamide resistance in M ycobacterium tuberculosis by molecular docking. Int J Appl Biol Pharma Tech.2011;2:19-29.

1094.  Natarajan PL, Ponnuraja C, Narayanan S. Mitogen activated protein kinase Influence the immune response of a prevalent Mycobacterium tuberculosis clinical strain of the Indo-Oceanic Clade. J Infect Dis Imm.2011;3:193-209.

1095.  Arun Kumar N, Venkatesan P. Recent advancements in causal inference. Int J Pharmaceut Studies Res.2011;II:10-19.

1096.  Babu S, Anuradha R, Pavan Kumar N, George PJ, Kumaraswami V, Nutman TB. Filarial lymphatic pathology reflects augmented toll-like receptor-mediated, mitogen-activated protein kinase-mediated proinflammatory cytokine production. Infect Immun.2011;79:4600-4608.

1097.  Basirudeen S, Rajasekaran S, Raja A. Comparison of interferon gamma– inducible protein-10 and interferon gamma– based QuantiFERON TB gold assays with tuberculin skin test in HIV-infected subjects. Diag Microbiol Infect Dis.2011;71 : 236-243.

1098.  Kumar NP, Anuradha R, Suresh R, Ganesh R, Shankar J, Kumaraswami V, Nutman TB, Babu S. Suppressed type 1, type 2 and type 17 cytokine responses in active tuberculosis in children. Clin Vaccine Immunol.2011;18:1856-1864.

1099.  Kumar AK, Sudha V, Srinivasan R, Ramachandran G. Simple and rapid liquid chromatogrpahy method for determination of moxifloxacin in saliva. J Chromatogr B Analyt Technol Biomed Life Sci.2011;879:3663-3667.

1100.  Hassan S, Logambiga P, Raman AM, Subazini TK, Kumaraswami V, Hanna LE. MtbSD–A comprehensive structural database for Mycobacterium tuberculosis . Tuberculosis.2011; 91:556-562.

1101.  Thomas BE, Suhadev M, Mani J, Ganapathy BG, Armugam A, Faizunnisha F, Chelliah M, Wares F. Feasibility of an alcohol intervention programme for TB patients with alcohol use disorder (AUD) - A qualitative study from Chennai, south India . PLoS One.2011;6:1-9.

1102.  Shah I, Swaminathan S, Ramachandran G, Kumar AK , Goray A, Chaddha U, Tayal S, Lala M. Serum nevirapine and efavirenz concentrations and effect of concomitant rifampicin in HIV infected children on antiretroviral therapy. Indian Ped.2011;48:943-947.

1103.  Venkatesan P , Raman TT, Ponnuraja C. Survival analysis of women with breast cancer under adjuvant therapy in south India . Asian Pac J Cancer Prev . 2011;12:1543-1545.

1104.  Unissa AN, Selvakumar N, Narayanan S. Characterization of isoniazid-resistant mutant (S315R) of catalase-peroxidase, KatG, from Mycobacterium tuberculosis. Int J Med Sci Technol. 2011;4:13-22.

1105.  Lakshmi R, Kumar V, Baskaran M, Sundar S, Rahman F, Selvakumar N, Ranjani R. Pattern of ethionamide susceptibility and its association with isoniazid resistance among previously treated tuberculosis patients from India . Braz J Infect Dis .2011;15:619-620.

1106. Unissa AN, Narayanan S, Suganthi C, Selvakumar N. Detection of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India using Ser315Thr marker by comparison of molecular methods. Int J Mol Clin Microbiol.2011;1:52-59.

1107.  Unissa AN, Narayanan S, Selvakumar N. Virulence in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from south India . Int J Mol Clin Microbiol.2011;1:87-96.

1108.  Padmapriyadarsini C, Narendran G, Swaminathan S. Diagnosis & treatment of tuberculosis in HIV co-infected patients. Indian J Med Res.2011;134:850-865.

1109.  Thomas B, Mimiaga MJ, Kumar S, Swaminathan S, Safren SA, Mayer KH. HIV in Indian MSM: Reasons for a concentrated epidemic & strategies for prevention. Indian J Med Res.2011;134:920-929.

1110.  Shiny C, Krushna NS , Babu S, Elango S, Manokaran G, Narayanan RB. Recombinant Wolbachia heat shock protein 60 (HSP60) mediated immune responses in patients with lymphatic filariasis. Microbes Infect.2011;13:1221-1231.